Johna Lucas

1.8k total citations
22 papers, 1.1k citations indexed

About

Johna Lucas is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Clinical Psychology. According to data from OpenAlex, Johna Lucas has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 15 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Clinical Psychology. Recurrent topics in Johna Lucas's work include Sexual function and dysfunction studies (19 papers), Hormonal and reproductive studies (12 papers) and Sexuality, Behavior, and Technology (8 papers). Johna Lucas is often cited by papers focused on Sexual function and dysfunction studies (19 papers), Hormonal and reproductive studies (12 papers) and Sexuality, Behavior, and Technology (8 papers). Johna Lucas collaborates with scholars based in United States, Czechia and United Kingdom. Johna Lucas's co-authors include James A. Simon, Akshay Buch, Glenn D. Braunstein, Cynthia Rodenberg, Molly Katz, Lila E. Nachtigall, Anita H. Clayton, Nelson B. Watts, Jan L. Shifren and Oscar Aguirre and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Urology and Obstetrics and Gynecology.

In The Last Decade

Johna Lucas

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johna Lucas United States 11 716 711 227 207 155 22 1.1k
Molly Katz United States 6 701 1.0× 652 0.9× 190 0.8× 217 1.0× 117 0.8× 7 970
Jan Shifren United States 3 495 0.7× 704 1.0× 216 1.0× 99 0.5× 159 1.0× 5 943
Valentina Boddi Italy 19 657 0.9× 701 1.0× 135 0.6× 240 1.2× 200 1.3× 29 1.0k
Regula E. Bürki United States 5 350 0.5× 484 0.7× 155 0.7× 77 0.4× 99 0.6× 8 679
Alain Moufarege Australia 6 331 0.5× 420 0.6× 121 0.5× 69 0.3× 86 0.6× 9 565
Douglas Lording Australia 13 323 0.5× 550 0.8× 248 1.1× 134 0.6× 147 0.9× 22 880
L.J.G. Gooren Netherlands 14 217 0.3× 788 1.1× 231 1.0× 88 0.4× 308 2.0× 29 1.2k
Valerio Chiarini Italy 11 595 0.8× 670 0.9× 108 0.5× 146 0.7× 199 1.3× 12 865
Friedemann Scheller Germany 16 489 0.7× 440 0.6× 73 0.3× 82 0.4× 86 0.6× 28 642
Domenico Canale Italy 15 81 0.1× 315 0.4× 327 1.4× 51 0.2× 208 1.3× 44 923

Countries citing papers authored by Johna Lucas

Since Specialization
Citations

This map shows the geographic impact of Johna Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johna Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johna Lucas more than expected).

Fields of papers citing papers by Johna Lucas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johna Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johna Lucas. The network helps show where Johna Lucas may publish in the future.

Co-authorship network of co-authors of Johna Lucas

This figure shows the co-authorship network connecting the top 25 collaborators of Johna Lucas. A scholar is included among the top collaborators of Johna Lucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johna Lucas. Johna Lucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simon, James A., Sheryl A. Kingsberg, David Portman, et al.. (2022). Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide. Journal of Women s Health. 31(3). 391–400. 4 indexed citations
2.
Clayton, Anita H., Sheryl A. Kingsberg, David Portman, et al.. (2022). Safety Profile of Bremelanotide Across the Clinical Development Program. Journal of Women s Health. 31(2). 171–182. 5 indexed citations
3.
Koochaki, Patricia, Dennis A. Revicki, Hilary Wilson, et al.. (2021). The Patient Experience of Premenopausal Women Treated with Bremelanotide for Hypoactive Sexual Desire Disorder: RECONNECT Exit Study Results. Journal of Women s Health. 30(4). 587–595. 10 indexed citations
4.
Derogatis, Leonard R., Dennis A. Revicki, Raymond C. Rosen, et al.. (2021). Psychometric validation of the Female Sexual Distress Scale-Desire/Arousal/Orgasm. Journal of Patient-Reported Outcomes. 5(1). 100–100. 16 indexed citations
5.
Revicki, Dennis A., Stanley E. Althof, Leonard R. Derogatis, et al.. (2020). Reliability and validity of the elements of desire questionnaire in premenopausal women with hypoactive sexual desire disorder. Journal of Patient-Reported Outcomes. 4(1). 82–82. 3 indexed citations
6.
Kingsberg, Sheryl A., Anita H. Clayton, David Portman, et al.. (2019). Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder. Obstetrics and Gynecology. 134(5). 899–908. 89 indexed citations
7.
Simon, James A., Sheryl A. Kingsberg, David Portman, et al.. (2019). Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder. Obstetrics and Gynecology. 134(5). 909–917. 35 indexed citations
8.
Althof, Stanley E., Leonard R. Derogatis, Sally Greenberg, et al.. (2019). Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide. The Journal of Sexual Medicine. 16(8). 1226–1235. 18 indexed citations
9.
Clayton, Anita H., Sheryl A. Kingsberg, James A. Simon, Robert Jordan, & Johna Lucas. (2018). Efficacy of Bremelanotide for HSDD in Women: RECONNECT Open-Label Extension Phase Results [8Q]. Obstetrics and Gynecology. 131(1). 186S–186S. 4 indexed citations
10.
Koochaki, Patricia, Dennis A. Revicki, Hilary Wilson, et al.. (2018). Exit Survey of Women with HSDD Treated With Bremelanotide Demonstrated Meaningful Treatment Benefits [28G]. Obstetrics and Gynecology. 131(1). 82S–82S. 2 indexed citations
11.
Clayton, Anita H., Johna Lucas, Leonard R. Derogatis, & Robert Jordan. (2017). Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants. Clinical Therapeutics. 39(3). 514–526.e14. 13 indexed citations
12.
White, William B., Martin G. Myers, Robert Jordan, & Johna Lucas. (2016). Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide. Journal of Hypertension. 35(4). 761–768. 9 indexed citations
13.
Clayton, Anita H., Stanley E. Althof, Sheryl A. Kingsberg, et al.. (2016). Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial. Women s Health. 12(3). 325–337. 69 indexed citations
14.
Kingsberg, Sheryl A., et al.. (2013). Characterization of Orgasmic Difficulties by Women: Focus Group Evaluation. The Journal of Sexual Medicine. 10(9). 2242–2250. 12 indexed citations
15.
Nachtigall, Lila E., et al.. (2010). Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen. Gynecological Endocrinology. 27(1). 39–48. 58 indexed citations
16.
Braunstein, Glenn D., Marcelo Katz, Jan L. Shifren, et al.. (2006). Safety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women: a Randomized, Placebo-Controlled Trial. The Journal of Urology. 175(2). 660–660. 55 indexed citations
17.
Braunstein, Glenn D., Molly Katz, Jan L. Shifren, et al.. (2005). Safety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women. Archives of Internal Medicine. 165(14). 1582–1582. 310 indexed citations
18.
Simon, James A., Glenn D. Braunstein, Lila E. Nachtigall, et al.. (2005). Testosterone Patch Increases Sexual Activity and Desire in Surgically Menopausal Women with Hypoactive Sexual Desire Disorder. The Journal of Clinical Endocrinology & Metabolism. 90(9). 5226–5233. 343 indexed citations
19.
Sarbaugh, Frank C., et al.. (2001). Clinical Safety in Use of a Layered-Fiber Tampon. Obstetrics and Gynecology. 97(Supplement). 19S–20S. 2 indexed citations
20.
Genant, Harry K., Johna Lucas, Stuart Weiss, et al.. (1998). Low-Dose Esterified Estrogen Therapy. Obstetrical & Gynecological Survey. 53(6). 363–364. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Molly Katz Breakdown of academic impact, for papers by Jan Shifren Breakdown of academic impact, for papers by Valentina Boddi Breakdown of academic impact, for papers by Regula E. Bürki Breakdown of academic impact, for papers by Alain Moufarege Breakdown of academic impact, for papers by Douglas Lording Breakdown of academic impact, for papers by L.J.G. Gooren Breakdown of academic impact, for papers by Valerio Chiarini Breakdown of academic impact, for papers by Friedemann Scheller Breakdown of academic impact, for papers by Domenico Canale
Rankless by CCL
2026